Alla Patlis
Fortuna: 108 262 $ al 31/05/2026
Fortuna: 108 262 $ al 31/05/2026
Alla Patlis currently works at Brainstorm Cell Therapeutics, Inc., as Chief Financial Officer & Controller from 2021.
Ms. Patlis also formerly worked at Deloitte Touche Tohmatsu Ltd., as Member.
Ms. Patlis received her undergraduate degree and Masters Business Admin degree from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/02/2026 | 144.349 ( 1,31 % ) | 108 262 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director Financiero/CFO | 31/08/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Provides auditing, consulting, financial and risk advisory & tax services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Provides auditing, consulting, financial and risk advisory & tax services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.